Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma.
Altaha
Ramin
R
Section of Hematology/Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia, USA. raltaha@hsc.wvu.edu
Crowell
Edward
E
Hobbs
Gerry
G
Higa
Gerry
G
Abraham
Jame
J
D014408:Biomarkers, Tumor / Q000032:analysis*; D001932:Brain Neoplasms / Q000556:secondary*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D016016:Proportional Hazards Models; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D016019:Survival Analysis; D015854:Up-Regulation
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases